CDT Equity Inc.
CDT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001896212
In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $94.7K in total; no superinvestor holds it.
Other share classesCDTTW
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by CDT Equity Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, – in total
- Insiders trading
- 1
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for CDT Equity Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Regan Andrew | Chief Executive Officer | 5,692,933Indirect | Sep 2, 2026 | 3 |
| Taylor Mark Andrew | 10% Owner | 0Indirect | Jun 23, 2026 | 2 |
| Prospect Capital Securities Ltd | 10% Owner | 0Indirect | Jun 23, 2026 | 2 |
| Prospect Finance Ltd | 10% Owner | 0Indirect | Jun 23, 2026 | 2 |
| Farley Chele Chiavacci | Director | 17,157 | Feb 23, 2026 | 1 |
| Corvus Capital Ltd. | 10% Owner | 227,304Indirect | Dec 22, 2025 | 1 |
| Bligh James | CFO | 480,024 | Sep 19, 2025 | 0 |
| Lewis-Hall Freda C | Director | 38,466 | Aug 26, 2025 | 0 |
| Fry Simon Jeremy | Director | 36,956 | Aug 26, 2025 | 0 |
| Charles Faith L. | Director | 165,238 | Apr 17, 2025 | 0 |
| Tapolczay David | Chief Executive Officer | – | Nov 20, 2024 | 0 |
| Stockton Ltd | 10% Owner | 6,092,000 | Oct 7, 2024 | 0 |
| Nirland Ltd | 10% Owner | 6,092,000 | Oct 7, 2024 | 0 |
| Dovet Ltd | 10% Owner | 6,092,000 | Oct 7, 2024 | 0 |
| Rowland Master Trust | 10% Owner | 6,092,000 | Oct 7, 2024 | 0 |
| Algo Holdings, Inc. | 10% Owner | 177,627Indirect | Sep 19, 2024 | 0 |
| McNealey Jennifer Isacoff | Director | – | May 15, 2024 | 0 |
| Sragovicz Adam | Chief Financial Officer | 0 | May 15, 2024 | 0 |
| Intelmed LLC | Other: See Responses | – | Apr 24, 2024 | 0 |
| Heilbron Jack Kendrick | Other: Former CEO,director&10% owner | 4,015,250Indirect | Sep 26, 2023 | 0 |
| Murphy Canyon Acquisition Sponsor, LLC | Other: Former 10% owner | 4,015,250Indirect | Sep 26, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 (view filing)6:12 PM ET | Aug 28 | 5 daysLate | Regan AndrewChief Executive Officer | SSale | −290 | – | – | 0.0%5.69M after | |
| Jun 23, 2026 (view filing)6:40 PM ET | Jun 18 | 5 days | Taylor Mark Andrew and 2 others10% Owner | SSale | −2.07M | $1.42 | −$2.95M | −100.0%0 after | 4 lots |
| Oct 7, 2024 (view filing)7:38 PM ET | Oct 3-7 | 4 days | Stockton Ltd and 3 others10% Owner | SSaleCommon Stock, par value $0.0001 per share | −3.81M | $0.1033 | −$393.4K | −38.5%6.09M after | 3 lots |
| Oct 2, 2024 (view filing)5:02 PM ET | Sep 30-Oct 2 | 2 days | Stockton Ltd and 3 others10% Owner | SSaleCommon Stock, par value $0.0001 per share | −2.60M | $0.1145 | −$297.6K | −20.8%9.90M after | 3 lots |
| Sep 19, 2024 (view filing)5:01 PM ET | Jul 3-17 | 78 daysLate | Regan Andrew and 2 othersDirector, 10% Owner | SSale | −15.3M | $0.3001 | −$4.59M | −98.9%177.6K after | 10 lots |
| Apr 24, 2024 (view filing) | Apr 22 | 2 days | Farley Chele ChiavacciDirector | PPurchase | +200.3K | – | – | –203.3K after | Derivative |
| Apr 24, 2024 (view filing) | Apr 22 | 2 days | Tapolczay DavidChief Executive Officer | SSale | −200.3K | – | – | –200.3K after | Derivative |